Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayral

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Neurobiology of Aging|April 24, 2025
Calpain and caspase regulate Aβ peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2Chloé Najdek, Pauline Walle, Amandine Flaig, et al.
Journal of Alzheimer'S Disease : JAD|August 10, 2010
Is the urea cycle involved in Alzheimer's disease?Franck Hansmannel, Adeline Sillaire, M Ilyas Kamboh, et al.
Journal of Medicinal Chemistry|December 9, 2009
Lead optimization of N-3-substituted 7-morpholinotriazolopyrimidines as dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors: discovery of PKI-402Christoph M Dehnhardt, Aranapakam M Venkatesan, Efren Delos Santos, et al.
Journal of Medicinal Chemistry|March 26, 2009
Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4Hwei-Ru Tsou, Xiaoxiang Liu, Gary Birnberg, et al.
Journal of Medicinal Chemistry|November 10, 2009
Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituentJeroen C Verheijen, David J Richard, Kevin Curran, et al.
Journal of Medicinal Chemistry|February 20, 2010
Bis(morpholino-1,3,5-triazine) derivatives: potent adenosine 5'-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: discovery of compound 26 (PKI-587), a highly efficacious dual inhibitorAranapakam M Venkatesan, Christoph M Dehnhardt, Efren Delos Santos, et al.
Virology Journal|February 22, 2014
Detection and genetic characterization of Seoul virus from commensal brown rats in FranceTatiana Dupinay, Kieran C Pounder, Florence Ayral, et al.
Cancer Biology & Therapy|April 23, 2005
PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumorsKer Yu, Judy Lucas, Tianmin Zhu, et al.
Neurology|September 16, 2025
Association of DTI-ALPS Glymphatic Index With Differential Phenoconversion in Isolated REM Sleep Behavior Disorder: A Multi-Cohort MRI StudyViolette Ayral, Alexandre Pastor-Bernier, Véronique Daneault, et al.
Cancer Research|April 19, 2003
HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivoFrank Loganzo, Carolyn M Discafani, Tami Annable, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Neurobiology of Aging|April 24, 2025
Calpain and caspase regulate Aβ peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2Chloé Najdek, Pauline Walle, Amandine Flaig, et al.
Journal of Alzheimer'S Disease : JAD|August 10, 2010
Is the urea cycle involved in Alzheimer's disease?Franck Hansmannel, Adeline Sillaire, M Ilyas Kamboh, et al.
Journal of Medicinal Chemistry|December 9, 2009
Lead optimization of N-3-substituted 7-morpholinotriazolopyrimidines as dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors: discovery of PKI-402Christoph M Dehnhardt, Aranapakam M Venkatesan, Efren Delos Santos, et al.
Journal of Medicinal Chemistry|March 26, 2009
Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4Hwei-Ru Tsou, Xiaoxiang Liu, Gary Birnberg, et al.
Journal of Medicinal Chemistry|November 10, 2009
Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituentJeroen C Verheijen, David J Richard, Kevin Curran, et al.
Journal of Medicinal Chemistry|February 20, 2010
Bis(morpholino-1,3,5-triazine) derivatives: potent adenosine 5'-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: discovery of compound 26 (PKI-587), a highly efficacious dual inhibitorAranapakam M Venkatesan, Christoph M Dehnhardt, Efren Delos Santos, et al.
Virology Journal|February 22, 2014
Detection and genetic characterization of Seoul virus from commensal brown rats in FranceTatiana Dupinay, Kieran C Pounder, Florence Ayral, et al.
Cancer Biology & Therapy|April 23, 2005
PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumorsKer Yu, Judy Lucas, Tianmin Zhu, et al.
Neurology|September 16, 2025
Association of DTI-ALPS Glymphatic Index With Differential Phenoconversion in Isolated REM Sleep Behavior Disorder: A Multi-Cohort MRI StudyViolette Ayral, Alexandre Pastor-Bernier, Véronique Daneault, et al.
Cancer Research|April 19, 2003
HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivoFrank Loganzo, Carolyn M Discafani, Tami Annable, et al.
Pageof 22